XML 34 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated and Combined Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue:      
Collaborative arrangement revenue $ 26,921 $ 115,594 $ 5,740
Total revenues 54,522 248,122 44,296
Operating expenses:      
Research and development 261,937 296,467 297,645
Selling, general and administrative 93,506 90,897 81,646
Share of collaboration loss 10,071 0 0
Cost of royalty and other revenue 2,517 5,396 2,978
Change in fair value of contingent consideration 439 (6,468) 2,747
Total operating expenses 368,470 386,292 385,016
Loss from operations (313,948) (138,170) (340,720)
Interest income, net 88 0 0
Other income, net 21,647 18,056 20,126
Loss before income taxes (292,213) (120,114) (320,594)
Income tax (expense) benefit 0 0 0
Net loss $ (292,213) $ (120,114) $ (320,594)
Net loss per share - basic (in dollars per share) $ (12.44) $ (5.14) $ (13.72)
Net loss per share - diluted (in dollars per share) $ (12.44) $ (5.14) $ (13.72)
Weighted-average number of common shares used in computing net loss per share - basic 23,499 23,369 23,369
Weighted-average number of common shares used in computing net loss per share - diluted 23,499 23,369 23,369
Other comprehensive loss:      
Other comprehensive loss, net of tax benefit (expense) of $0.0 million, $0.0 million, and $0.0 million for the years ended December 31, 2021, 2020 and 2019, respectively $ (712) $ 0 $ 0
Comprehensive loss (292,925) (120,114) (320,594)
Service revenue      
Revenue:      
Revenue 21,381 111,452 30,351
Royalty and other revenue      
Revenue:      
Revenue $ 6,220 $ 21,076 $ 8,205